# Effect of Xuebijing InjecTion on Outcomes in Sepsis Patients Under Real-World Conditions（EXIT-SEP REAL）

> **NCT07069894** · — · NOT_YET_RECRUITING · sponsor: **Southeast University, China** · enrollment: 5400 (estimated)

## Conditions studied

- Sepsis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07069894
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-10
- **Final completion:** 2027-09
- **Target enrollment:** 5400 (ESTIMATED)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07069894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07069894, "Effect of Xuebijing InjecTion on Outcomes in Sepsis Patients Under Real-World Conditions（EXIT-SEP REAL）". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07069894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*